Previous Article | Next Article 
Journal of Clinical Microbiology, January 2006, p. 225-226, Vol. 44, No. 1
0095-1137/06/$08.00+0 doi:10.1128/JCM.44.1.225-226.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Community-Associated Methicillin-Resistant Staphylococcus aureus Epidemic Clone USA300 in Isolates from Florida and Washington
Jill C. Roberts,1*
Robin L. Krueger,1
K. Kealy Peak,1
William Veguilla,1
Andrew C. Cannons,1
Philip T. Amuso,1,2 and
Jacqueline Cattani1
Center for Biological Defense, University of South Florida College of Public Health,1
Bureau of LaboratoriesTampa, Florida Department of Health, Tampa, Florida 336122
Received 2 September 2005/
Returned for modification 17 October 2005/
Accepted 25 October 2005

ABSTRACT
We examined 299 methicillin-resistant, community-associated
Staphylococcus aureus isolates from Florida and Washington State
for the presence of the USA300 epidemic clone. Pulsed-field
gel electrophoresis demonstrated the epidemic clone in 43% of
our
S. aureus strains and in isolates from both states. The
majority of the USA300 isolates (88%) were from wound infections.

TEXT
Recent publications have suggested that community-acquired methicillin-resistant
Staphylococcus aureus (CA-MRSA) infections are becoming commonplace
and that particular
S. aureus clones feature prominently in
epidemics occurring in the United States (
1,
2,
6,
7). A specific
MRSA clone that is multilocus sequence type 8 (ST8) and pulsotypes,
designated USA300 by the Centers for Disease Control and Prevention
(
6), has been identified in community outbreaks of MRSA wound
infections in California, Georgia, Texas, Pennsylvania, Mississippi,
and Minnesota (
1,
4,
7). USA300 carries the type IV staphylococcal
methicillin resistance gene cassette (SCC
mec IV) (
6) and produces
Panton-Valentine leucocidin, a virulence factor that is linked
to cases of community-acquired necrotizing pneumonia (
3,
5,
10). In the present study, we examined community-associated
MRSA isolates collected from individuals in Florida and Washington
State with a variety of disease etiologies by pulsed-field gel
electrophoresis (PFGE) for the presence of the epidemic USA300
clone.
A total of 299 community-associated methicillin-resistant S. aureus organisms isolated from wounds, noses, sputa, blood, and other sources were used in this study. CA-MRSA isolates were requested from two hospitals in Washington, one hospital in Florida, and a reference laboratory in Florida. All isolates were collected from patients treated on an outpatient basis, within 48 h of consultation, and only one isolate was obtained per patient. The control strain, a USA300 (NRS384), was obtained from the Network on Antimicrobial Resistance in S. aureus.
PFGE was performed as previously reported for enterococcal isolates (8) with the following changes for S. aureus. Overnight cultures of S. aureus were grown in BBL Trypticase soy broth (Becton Dickinson, Sparks, MD). Lysostaphin (Sigma, St. Louis, MO) was added to the cell lysis buffer (6 mM Tris-HCl, 1 M NaCl, 100 mM EDTA, 0.5% Brij-58, 0.2% sodium deoxycholate, 0.5% sodium lauroyl sarcosine) at a concentration of 3 U/ml, and plugs were lysed at 37°C, followed by overnight incubation in a solution containing 0.5 M EDTA (pH 9), 1% sodium lauroyl sarcosine, and 50 µg/ml proteinase K at 50°C. Plugs were digested in SmaI overnight, melted at 69°C, and loaded onto a 1% Seakem Gold (Cambrex BioScience, Rockland, ME) gel. PFGE was performed using a DR-II CHEF Mapper (Bio-Rad, Hercules, CA) using the following parameters: 200 V, 14°C, 5.3-s initial switch, 34.9-s final switch, and 20-h run time. Data were analyzed using BioNumerics (Applied Math, Sint-Martens, Belgium). Dendrograms were derived from unweighted-pair group method using arithmetic averages (UPGMA) and based on Dice coefficients. PCR for the pvl genes was performed as previously reported (5).
A number of studies have demonstrated an epidemiologic link between the USA300 epidemic clone and CA-MRSA infections (1, 4, 6, 7). These studies have demonstrated the presence of this isolate in wound infections in six states (1, 4, 6, 7). In our study, we used PFGE to examine CA-MRSA isolates from Florida and Washington State for the presence of the USA300 clone. While our collection of 299 isolates contained 39 isolates from Washington, the majority (260, 87%) of the isolates were collected in Florida. USA300, as designated by the CDC, includes two closely related PFGE patterns, or pulsotypes (6). In the present study, we found that 44% (17 of 39) of our Washington isolates and 42% (111 of 260) of our Florida CA-MRSA isolates have the same pulsotypes as USA300, using SmaI digestion, demonstrating the presence of the epidemic clone in these two states (Fig. 1). Although the control strain represents only one of two possible USA300 patterns, a one-band difference as shown in Fig. 1 (CBD739) is still considered identical by widely accepted criteria (9). Furthermore, the CBD739 pulsotype appears to be identical to the alternative USA300 pattern represented in publication (6) but not available as a control strain.
Previous studies have demonstrated that the USA300 isolates
contain the Panton-Valentine leucocidin (
pvl) genes which have
been epidemiologically linked to severe skin infections and
necrotizing pneumonia (
3,
5,
10). The
pvl genes encode membrane
toxins which target leukocytes, and therefore, not surprisingly,
the studies of USA300 have primarily involved isolates from
wound infections (
1,
4,
7). To expand the investigation of the
spread of this epidemic clone, we included in our pulsed-field
analysis, in addition to wound isolates, organisms isolated
from other sites (Table
1). Using BioNumerics software (Fig.
1), we found that the majority of CA-MRSA isolates were isolated
from wounds, and the majority of these isolates (64%) belonged
to the USA300 pulsotypes (Table
1). Although USA300 pulsotypes
were present in different types of infections, e.g., blood (12%),
nose (15%), sputum (10%), and other (5%) (Fig.
1), they accounted
for a small number of these isolates. PCR results demonstrated
that 100% of our USA300 isolates carry the
pvl locus (data not
shown). In addition to having methicillin resistance, 97% of
the USA300 isolates tested were resistant to macrolides, and
22% were resistant to clindamycin (Vicki Luna, personal communication).
Multilocus sequence typing performed on select USA300 isolates
confirmed that all are ST8 as previously reported (
6) (data
not shown). These results further confirm earlier studies that
showed that there is a strong correlation between the USA300
pulsotypes and wound infections (
1,
4,
7). Additionally, these
results demonstrate that while these pulsotypes are not unique
to wound infections, they are uncommon in the other
S. aureus infections included in this study.
The remaining 149 isolates on which PFGE was performed included
1 isolate that was a match to the USA400 epidemic clone, several
isolates that are closely related to USA100, and several isolates
with unique patterns (data not shown). The majority of the USA100-like
isolates in our collection were obtained from nasal swabs, and
99% of these isolates were PCR negative for the
pvl locus, but
it is unknown if they were present as a result of infection
or colonization.
In conclusion, the epidemic CA-MRSA USA300/ST8 clone, as previously reported in six states, is also present in Florida and Washington. We have further strengthened the evidence for an epidemiological link between USA300 and wound infections by demonstrating that these pulsotypes cause the majority of CA-MRSA wound infections in our database and all are positive for the pvl genes. We have also demonstrated the presence of USA300 in isolates from blood, sputum, nose, and conjunctiva (Table 1), although they accounted for a minority of the isolates.

ACKNOWLEDGMENTS
We thank Vicki Luna for obtaining the
S. aureus isolates used
in this study.
This study was supported by U.S. Army Research, Development and Engineering Command, contract DAAD13-01-C-0043.

FOOTNOTES
* Corresponding author. Mailing address: MPH Center for Biological Defense, Department of Global Health, University of South Florida, College of Public Health, 3602 Spectrum Blvd., MDC 56, Tampa, FL 33612. Phone: (813) 974-3429. Fax: (813) 974-1479. E-mail:
jroberts{at}bt.usf.edu.


REFERENCES
1 - Chambers, H. F. 2005. Community-associated MRSA resistance and virulence converge. N. Engl. J. Med. 352:1485-1487.[Free Full Text]
2 - Fridkin, S. K., J. C. Hageman, M. Morrison, L. T. Sanza, K. Como-Sabetti, J. A. Jernigan, K. Harriman, L. H. Harrison, R. Lynfield, and M. M. Farley. 2005. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352:1436-1444.[Abstract/Free Full Text]
3 - Gillet, Y., B. Issartel, P. Vanhems, J. C. Fournet, G. Lina, M. Bes, F. Vandenesch, Y. Piemont, N. Brousse, D. Floret, and J. Etienne. 2002. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753-759.[CrossRef][Medline]
4 - Kazakova, S. V., J. C. Hageman, M. Matava, A. Srinivasan, L. Phelan, B. Garfinkel, T. Boo, S. McAllister, J. Anderson, B. Jensen, D. Dodson, D. Lonsway, L. K. McDougal, M. Arduino, V. J. Fraser, G. Killgore, F. C. Tenover, S. Cody, and D. B. Jernigan. 2005. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352:468-475.[Abstract/Free Full Text]
5 - Lina, G., Y. Piemont, F. Godail-Gamot, M. Bes, M. O. Peter, V. Gauduchon, F. Vandenesch, and J. Etienne. 1999. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29:1128-1132.[CrossRef][Medline]
6 - McDougal, L. K., C. D. Steward, G. E. Killgore, J. M. Chaitram, S. K. McAllister, and F. C. Tenover. 2003. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:5113-5120.[Abstract/Free Full Text]
7 - Miller, L. G., F. Perdreau-Remington, G. Rieg, S. Mehdi, J. Perlroth, A. S. Bayer, A. W. Tang, T. O. Phung, and B. Spellberg. 2005. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N. Engl. J. Med. 352:1445-1453.[Abstract/Free Full Text]
8 - Murray, B. E., K. V. Singh, J. D. Heath, B. R. Sharma, and G. M. Weinstock. 1990. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J. Clin. Microbiol. 28:2059-2063.[Abstract/Free Full Text]
9 - Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.[Medline]
10 - Vandenesch, F., T. Naimi, M. C. Enright, G. Lina, G. R. Nimmo, H. Heffernan, N. Liassine, M. Bes, T. Greenland, M. E. Reverdy, and J. Etienne. 2003. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg. Infect. Dis. 9:978-984.[Medline]
Journal of Clinical Microbiology, January 2006, p. 225-226, Vol. 44, No. 1
0095-1137/06/$08.00+0 doi:10.1128/JCM.44.1.225-226.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Luna, V. A., Xu, Z.-Q., Eiznhamer, D. A., Cannons, A. C., Cattani, J.
(2008). Susceptibility of 170 isolates of the USA300 clone of MRSA to macrolides, clindamycin and the novel ketolide cethromycin. J Antimicrob Chemother
62: 639-640
[Full Text]